Alvarez & Marsal India appoints Nitin Lath as MD in Corporate Finance
Appointment to focus on private equity and M&A advisory in life sciences sector
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Zydus receives approval to conduct Phase III trials of Zintrodiazine for malaria in India
Two studies to evaluate efficacy and safety in Plasmodium falciparum and Plasmodium vivax infections
Alembic Pharmaceuticals receives USFDA approval for Fingolimod Capsules ANDA
Approval for 0.5 mg capsules therapeutically equivalent to Novartis’ Gilenya; market size at US$ 145 million
FDD Conclave – Mumbai Connect: Reimagining formulation R&D
The inaugural edition of FDD Conclave - Mumbai Connect, a city-focused platform brought together FR&D leaders to discuss…
Umang Vohra appointed Executive Chairman and Group CEO of Cohance Lifesciences
Former Cipla CEO to lead next phase for CDMO platform focused on complex chemistry and APIs
Boehringer Ingelheim India, NIPER Hajipur sign MoU for research and education collaboration
Five-year agreement focuses on open science access, joint research and capability building
Sun Pharma to acquire Organon in US$ 11.75 billion all-cash transaction
Deal combines portfolios and expands presence across women’s health, biosimilars and global markets
IPC signs MoUs with PMBI and NIPER Hajipur to strengthen quality assurance and research
Agreements focus on medicine quality testing, pharmacovigilance, and pharmaceutical research collaboration
Raay Neo Pharma launches operations with portfolio of 90 formulations across therapy segments
Company outlines expansion across multiple states and pipeline of formulations under development
Kashiv BioSciences to be acquired by Amneal Pharmaceuticals
Transaction to create integrated global biosimilars platform combining development, manufacturing and commercial capabilities
PAGE partners with 8chili to launch AI and VR training platform for pharma manufacturing in India
Platform to support workforce development for quality, production and regulatory roles
Safeguarding the pharma excipients supply chain
Adding excipient details to QR codes of the top 300 drugs may not be a tough task. But as CDSCO plans to expand QR codes to cover…
Supriya Lifescience receives USFDA EIR with VAI classification for Lote Parshuram facility
Inspection cycle closed following February 2026 USFDA audit
Off label drug use and physician liability
Dr Amit Kumar, Assistant Professor of Law, Maharashtra National Law University Mumbai, examines the complex legal and ethical…
Lupin launches Dapagliflozin and Metformin extended-release tablets in the United States
USFDA approves ANDA for bioequivalent version of Xigduo XR
Zyax Chem acquires 26% stake in Gaymed Labs
Investment brings board representation and expansion plans in ophthalmic segment
OneSource and Orbicular secure USFDA tentative approval for generic semaglutide injection
Partnership progresses ANDA filing for generic version of Ozempic with manufacturing support from OneSource
India’s biopharma moment—If we get the ecosystem right
Krishna Sarma highlights the ecosystem requirements for advancing biopharma innovation in India
Morepen Laboratories clears fourth USFDA inspection at Masulkhana facility with NIL 483
Outcome follows Rs 825 crore CDMO mandate and supports global manufacturing engagements
Clinical exclusivity for indigenous medicines can improve long-term affordability and access
Nikkhil Masurkar, CEO, Entod Pharmaceuticals opines that in the absence of clinical data exclusivity, competitors may obtain…